OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine over one year of treatment: Pooled results from the PREEMPT randomized clinical trial program.
| Autor: | Lipton, Richard B.1,2 Richard.Lipton@einstein.yu.edu, Rosen, Noah L.3, Ailani, Jessica4, DeGryse, Ronald E.5, Gillard, Patrick J.5, Varon, Sepideh F.5 |
|---|---|
| Zdroj: | Cephalalgia. Aug2016, Vol. 36 Issue 9, p899-908. 10p. 1 Chart, 3 Graphs. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|